Xencor (XNCR) Enterprise Value (2013 - 2026)
Xencor (XNCR) reported Enterprise Value of -$74.7 million for Q1 2026, up 82.23% year-over-year from -$41.0 million in Q1 2025, and up 55.13% quarter-over-quarter from -$166.6 million in Q4 2025.
Xencor (XNCR) Enterprise Value (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Enterprise Value data on file, last reported at -$74.7 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$74.7 million, up 82.23% year-over-year; the trailing twelve-month figure through Mar 2026 was -$74.7 million (up 82.23% YoY), and the FY2025 annual result was -$166.6 million, down 80.3% from the prior year.
- Enterprise Value advanced to -$74.7 million in Q1 2026 per XNCR's latest filing, from -$166.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$74.7 million in Q2 2023 and troughed at -$580.6 million in Q4 2022.
- A 5-year average of -$324.6 million and a median of -$403.4 million in 2025 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2024: Enterprise Value jumped 84.6% in 2023, then sank 545.1% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$580.6 million in 2022, then grew by 5.07% to -$551.2 million in 2023, then surged by 83.24% to -$92.4 million in 2024, then plunged by 80.3% to -$166.6 million in 2025, then soared by 55.13% to -$74.7 million in 2026.
- Business Quant data shows XNCR's Enterprise Value at -$74.7 million in Q1 2026, -$166.6 million in Q4 2025, and -$386.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - | -74.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.74 Mn |
| Dec 31, 2025 | -166.58 Mn |
| Sep 30, 2025 | -386.78 Mn |
| Jun 30, 2025 | -403.43 Mn |
| Mar 31, 2025 | -420.70 Mn |
| Dec 31, 2024 | -92.39 Mn |
| Sep 30, 2024 | -467.01 Mn |
| Jun 30, 2024 | -481.92 Mn |
| Mar 31, 2024 | -75.91 Mn |
| Dec 31, 2023 | -551.18 Mn |
| Sep 30, 2023 | -465.56 Mn |
| Jun 30, 2023 | -74.71 Mn |
| Mar 31, 2023 | -112.10 Mn |
| Dec 31, 2022 | -580.63 Mn |
| Sep 30, 2022 | -568.05 Mn |
| Jun 30, 2022 | -485.03 Mn |
| Mar 31, 2022 | -111.70 Mn |
| Dec 31, 2021 | -180.34 Mn |
| Sep 30, 2021 | -88.78 Mn |
| Jun 30, 2021 | -161.07 Mn |